Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC is a research paper published in Journal of Thoracic Oncology (2023). On theSindex it has a DataRank of 0.489. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Memorial Sloan Kettering Cancer Center
Grant: 5R25CA020449
Memorial Sloan Kettering Cancer Center
Grant: P30 CA008748
NCI NIH HHS
Grant: R25 CA020449
NCI NIH HHS
Grant: P01 CA129243
National Institutes of Health
Brigham and Women's Hospital
FWCI
2.85
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals